Greek cig maker Papastratos cites target of 75% of net revenues by 2023 from innovative, alternative products
The development came just a few days before tobacco giant Philip Morris International announced on Friday that it would purchase UK-listed Vectura for 1.44 billion USD, giving the American multinational access to the British drug-maker's respiratory treatments and inhaling device technology.
- Επαναστατικός 3D βιοεκτυπωτής εκτυπώνει ανθρώπινους ιστούς «κατ’εικόνα και καθ’ομοίωσιν»
- «Όχι» Φαραντούρη σε πρόταση Φάμελλου για συνάντηση των 4 υποψηφίων πλην Κασσελάκη
- Η Κέιτ Μίντλετον όπως δεν την έχετε ξαναδεί- Η φωτογραφία της από τα χρόνια που φοιτούσε στο στο St. Andrews
- Γεραπετρίτης στη Χουριέτ: Όραμά μου μια γειτονιά μακράς ειρήνης και ευημερίας μεταξύ των λαών μας
Greece-based cigarette maker Papastratos this month announced the implementation of a sustainable growth strategy and corresponding commitments, coinciding with the 90th anniversary of the company’s establishment.
The development came just a few days before tobacco giant Philip Morris International announced on Friday that it would purchase UK-listed Vectura for 1.44 billion USD, giving the American multinational access to the British drug-maker’s respiratory treatments and inhaling device technology.
On its part, Papastratos pointed to a concerted effort to develop innovative products. In basing its strategy, the Greek company calculated that by 2025 cigarette smokers in Greece will decrease by 1.5 million, either by stopping the habit or by turning to other alternatives involving tobacco.
The target, Papastratos announced, is for 75 percent of its net revenues by 2023 to come from innovative and alternative products.
Ακολουθήστε το in.gr στο Google News και μάθετε πρώτοι όλες τις ειδήσεις